Efficacy of bovine lactoferrin supplementation in preventing late-onset sepsis in low birth weight neonates: A randomized placebo-Controlled clinical trial

Journal of Tropical Pediatrics

Volumn 61, Issue 5, 2015, Pages 370-376

  Kaur, Gurpreet ^a   Gathwala, Geeta ^a  

^a Institute of Medical Sciences   (India)

Author keywords

Bovine lactoferrin; Late onset sepsis; Low birth weight

Indexed keywords

LACTOFERRIN; PLACEBO; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ARTICLE; CANDIDA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KLEBSIELLA; LATE ONSET SEPSIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MORTALITY; NEWBORN; NEWBORN SEPSIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STAPHYLOCOCCUS AUREUS; SUPPLEMENTATION; TERTIARY CARE CENTER; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ANIMAL; BOVINE; DOSE RESPONSE; EPIDEMIOLOGY; INDIA; INFANT, PREMATURE, DISEASES; NEWBORN INTENSIVE CARE; PREMATURITY; SEPSIS; TREATMENT OUTCOME;

ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; INDIA; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; LACTOFERRIN; MALE; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 84944066590     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmv044     Document Type: Article

References (23)

1. Aggarwal R, Sarkar N, Deorari AK, et al. AIIMS protocols in Neonatology-II, Sepsis in the Newborn Indian. J Pediatr 2001;68:1143-7.
2. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research. Pediatrics 2002;110:285-91.
3. National Neonatology Forum NNPD Network. Report of the National Neonatal Perinatal Database 2002-2003. Department Of Paediatrics, AIIMS, New Delhi. 2003.
4. Sundaram V, Kumar P, Dutta S, et al. Blood culture confirmed bacterial sepsis in Neonates in a North Indian tertiary care center: changes over the last decade. Jpn J Infect Dis 2009;62:46-50.
5. Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci 2005;62:2588-98.
6. Sherman MP. New concepts of microbial translocation in the neonatal intestine: mechanisms and prevention. Clin Perinatol. 2010;37;565-79.
7. Bhimani RS, Vendrov Y, Furmanski P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 1999;86:135-44.
8. Venkatesh MP, Pham D, Kong L, et al. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection. Adv Ther 2007;24:941-54.
9. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defense. Biochem Cell Biol 2002;80:95-102.
10. Buccigrossi V, de Marco G, Bruzzese E, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007;61:410-14.
11. Davidson LA, Lönnerdal B. Persistence of human milk proteins in the breastfed infant. Acta Paediatr Scand 1987;76:733-40.
12. Kawakami H, Lönnerdal B. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am J Physiol 1991;261:G841-6.
13. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003;77: 1537S-43S.
14. Edde L, Hipolito RB, Hwang FFY, et al. Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 2001;281:G1140-50.
15. Guillen C, McInnes IB, Vaughan DM, et al. Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 2002:168;3950-7.
16. Gomez HF, Ochoa TJ, Herrera-Insua I, et al. Lactoferrin protects rabbits from Shigella flexneri-Induced inflammatory enteritis. Infect Immun 2002;70:7050-3.
17. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;5:CD007137.
18. Pammi M, Abrams SA. Oral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 2011;5:CD007138
19. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421-8.
20. Lubchenco L, Hansman C, Dressler M, et al. Intrauterine growth as estimated from live born birth weight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800.
21. Manzoni P, Stolfi I, Messner H, et al. Bovine lactoferrin prevents invasive fungal infections in very low birthweight infants: a randomized controlled trial. Pediatrics 2012;129;116-23
22. Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 2004;17:189-96.
23. Farnaud S, Evans RW. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol 2003;40:395-405.